Clinical Trials in Arizona

Showing 9901-9920 of 14,395 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

COMPLETEDPhase 231 miles

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

NCT00527735

The purpose of the study is to determine whether ipilimumab given with paclitaxel/carboplatin has clinical benefit when compared with paclitaxel/carboplatin alone in patients with previously untreated lung cancer.

Lung CancerSmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung

Bristol-Myers Squibb334 participantsStarted Feb 2008

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +69 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Find Trials by Condition in Arizona

A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Open Label Study of Long Term Safety Evaluation of Alirocumab

TARGET Intracranial Aneurysm Coiling Registry

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis